Skip to content

Effect of chamomile capsule in post term pregnancy

The effect of chamomile capsule on obstetrical outcomes in post term pregnancy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013062213737N1
Enrollment
70
Registered
2013-09-22
Start date
2013-06-25
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post term pregnancy. Post-dates

Interventions

Intervention 1: Oral chamomile capsules, starting since 40 weeks of gestational age completely, primary dose of 3 capsules of 500 mg every 8 hours to do a pilot study. Intervention 2: Placebo capsules
Treatment - Drugs
Placebo
Oral chamomile capsules, starting since 40 weeks of gestational age completely, primary dose of 3 capsules of 500 mg every 8 hours to do a pilot study
Placebo capsules, containing corn starch, 500 mg

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criterias: pregnant women 18-35 years old; Iranian nationality; have a body mass index less than 30 before pregnancy; low risk pregnancy; with getational age 41 weeks (40 weeks completely) based on LMP or ultrasound in first trimester; no history of recurrent abortion; infertility and undesirable outcomes of pregnancy; single pregnancy; cephalic presentation; alive fetus; weight of fetus between 2500-4000 gram based on physical examination or ultrasonography; cervical bishop score less than 4; intact membranous; normal pelvic according to researcher's exam; normall fetal heart rate and BPP and NST; no sensivity to herbal drugs and non-addicted persons. Exclusion criterias: those who consume them is less than one capsule per day, more than one care session is absent, and appears allergic symptoms.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Obstetrical outcomes. Timepoint: 2 weeks after intervention. Method of measurement: questionnair.

Secondary

MeasureTime frame
Placental outcomes. Timepoint: During the first week of intervention and labor. Method of measurement: Observation and record in questionnaire.;Fetal outcomes. Timepoint: During first week of intervention. Method of measurement: Observation and Record questionnaire.;Maternal outcomes. Timepoint: During first week of intervention. Method of measurement: Examination, observation and record questionnaire.;Neonatal outcomes. Timepoint: To 10 days after delivery. Method of measurement: Observation and record in questionnair.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFereshte Gholami Darbarazi

Tehran university of medical science, Nursing and Midwifery school

fereshte.gh86@gmail.com+98 21 6692 7171

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026